Additional file 1: of Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trialLaura Collett, Peter Hillmen, Adrian Bloor et al.|Figshare|2017Cited by 0